Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Rebamipide for diabetic nephropathy

July 3, 1997

Edex cleared for erectile dysfunction in the U.S.

July 2, 1997

Injectable microsphere-encapsulated norethindrone is a safe and effective contraceptive

July 2, 1997

Tokyo Tanabe developing oxytocin antagonist

July 2, 1997

Abbott and Metabolex enter diabetes collaboration

July 1, 1997

New hypoglycemic/insulin-sensitizing agent from Novartis

July 1, 1997

Phytopharm to develop naturally occurring antiobesity agent

June 30, 1997

Anika and Orquest sign manufacturing agreement

June 30, 1997

GelTex bile acid sequestrant not absorbed from GI tract in animals

June 30, 1997

Novel progestins/antiprogestins disclosed by Ortho

June 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...